PENGEMBANGAN FRIDEM SEBAGAI SCREENING TOOL DIABETES MELLITUS TIPE 2 BAGI MASYARAKAT INDONESIA

  • Susy Puspasari STIKep PPNI Jabar
  • Eva Supriatin STIKep PPNI Jabar
  • Suci Noor Hayati STIKep PPNI Jabar
  • Tri Antika Rizki Kusuma Putri STIKep PPNI Jabar
Keywords: Diabetes Mellitus, Faktor Risiko, FRIDEM

Abstract

Pentingnya usaha pencegahan untuk menekan angka kejadian Diabetes Mellitus Tipe 2 yang terus bertambah setiap tahunnya menuntut perlunya alat skrining yang tepat. Tidak hanya untuk mendeteksi berbagai faktor risiko namun juga instrumen yang sudah disesuaikan dengan karakteristik populasi Indonesia. Penelitian ini bertujuan untuk mengembangkan alat skrining Diabetes Mellitus Tipe 2 baru yang telah disesuaikan dengan karakteristik masyarakat Indonesia yang dievaluasi dengan menggunakan uji validitas dan reliabilitasnya. Kuesioner Faktor Risiko Diabetes Mellitus Tipe 2 (FRIDEM) diadaptasi berdasarkan American Diabetes Association-Risc (ADA Risc Test) dan Finnish Diabetes Risc Score (FINDRISC) yang telah melalui proses translasi dan dilanjutkan dengan uji validitas dan reliabilitas. Validitas item dilihat dari besarnya nilai r-tabel dengan r-hitung dan reliabilitas dilihat melalui koefisien cronbach-alpha. Penelitian ini menunjukkan bahwa instrumen FRIDEM memiliki total 10 item pertanyaan yang valid dan reliabel. Hal ini membuat FRIDEM dapat digunakan baik oleh tenaga kesehatan maupun masyarakat Indonesia.

Downloads

Download data is not yet available.

References

Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., Abegaz, K. H., Abolhassani, H., Aboyans, V., Abreu, L. G., Abrigo, M. R. M., Abualhasan, A., Abu-Raddad, L. J., Abushouk, A. I., Adabi, M., Adekanmbi, V., Adeoye, A. M., Adetokunboh, O. O., … Amini, S. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9

Abdallah, M., Sharbaji, S., Sharbaji, M., Daher, Z., Faour, T., Mansour, Z., & Hneino, M. (2020). Diagnostic accuracy of the Finnish Diabetes Risk Score for the prediction of undiagnosed type 2 diabetes, prediabetes, and metabolic syndrome in the Lebanese University. Diabetology and Metabolic Syndrome, 12(1), 1–11. https://doi.org/10.1186/s13098-020-00590-8

Agarwal, G., Guingona, M. M., Gaber, J., Angeles, R., Rao, S., & Cristobal, F. (2019). Choosing the most appropriate existing type 2 diabetes risk assessment tool for use in the Philippines: A case-control study with an urban Filipino population. BMC Public Health, 19(1), 1–9. https://doi.org/10.1186/s12889-019-7402-0

Buijsse, B., Simmons, R. K., Griffin, S. J., & Schulze, M. B. (2011). Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiologic Reviews, 33(1), 46–62. https://doi.org/10.1093/epirev/mxq019

Carvalho, J. A. M., Barengo, N. C., Tuomilehto, J., Conceição, R. D., & Santos, R. D. (2011). The finnish diabetes risk score (FINDRISC) as a screening tool for hepatic steatosis. Annals of Medicine, 43(6), 487–494. https://doi.org/10.3109/07853890.2011.554428

Costa, B., Barrio, F., Piñol, J. L., Cabré, J. J., Mundet, X., Sagarra, R., Salas-Salvadó, J., & Solà-Morales, O. (2013). Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy. BMC Medicine, 11(1). https://doi.org/10.1186/1741-7015-11-45

Creswell, J. (2016). Research design Pendekatan metode kuantatif, kualitatif, dan campura (1st ed.). Pustaka Pelajar.

Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014). Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Research and Clinical Practice, 103(2), 137–149. https://doi.org/10.1016/j.diabres.2013.11.002

Hussain, A., Bhowmik, B., & do Vale Moreira, N. C. (2020). COVID-19 and diabetes: Knowledge in progress. Diabetes Research and Clinical Practice, 162, 108142. https://doi.org/10.1016/j.diabres.2020.108142

Kemenkes RI. (2018). Hasil Utama Riset Kesehatan Dasar 2018 Kementrian Kesehatan Badan Penelitian dan Pengembangan Kesehatan. Balitbangkes.

Li, Y., Teng, D., Shi, X., Qin, G., Qin, Y., Quan, H., Shi, B., Sun, H., Ba, J., Chen, B., Du, J., He, L., Lai, X., Li, Y., Chi, H., Liao, E., Liu, C., Liu, L., Tang, X., … Shan, Z. (2020). Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: National cross sectional study. The BMJ, 369. https://doi.org/10.1136/bmj.m997

McGregor, M. S., Pinkham, C., Ahroni, J. H., Herter, C. D., & Doctor, J. D. (1995). The American Diabetes Association Risk Test for diabetes. Diabetes Care, 18(4), 585–586. https://doi.org/10.2337/diacare.18.4.585b

Nhim, K., Khan, T., Gruss, S. M., Wozniak, G., Kirley, K., Schumacher, P., Luman, E. T., & Albright, A. (2018). Primary Care Providers’ Prediabetes Screening, Testing, and Referral Behaviors. American Journal of Preventive Medicine, 55(2), e39–e47. https://doi.org/10.1016/j.amepre.2018.04.017

Paulweber, B., Valensi, P., Lindström, J., Lalic, N. M., Greaves, C. J., McKee, M., Kissimova-Skarbek, K., Liatis, S., Cosson, E., Szendroedi, J., Sheppard, K. E., Charlesworth, K., Felton, A. M., Hall, M., Rissanen, A., Tuomilehto, J., Schwarz, P. E., Roden, M., Paulweber, M., … Yilmaz, T. (2010). A European evidence-based guideline for the prevention of type 2 diabetes. Hormone and Metabolic Research, 42(SUPPL. 1), 3–37. https://doi.org/10.1055/s-0029-1240928

Scanlan, A. B., Maia, C. M., Perez, A., Homko, C. J., & O’Brien, M. J. (2018). Diabetes risk assessment in Latinas: Effectiveness of a brief diabetes risk questionnaire for detecting prediabetes in a community-based sample. Diabetes Spectrum, 31(1), 31–36. https://doi.org/10.2337/ds16-0051

Sugiono. (2016). Metode Penelitian Kuantitatif, Kualitatif, dan R&D (23rd ed.). Alvabeda.

Wild, D., Grove, A., Eremenco, S., McElroy, S., Verjee-Lorenz, A., & Erikson, P. (2005). Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation. Value in Health, 8(2), 94–104.

Zhang, M., Zhang, H., Wang, C., Ren, Y., Wang, B., Zhang, L., Yang, X., Zhao, Y., Han, C., Pang, C., Yin, L., Xue, Y., Zhao, J., & Hu, D. (2016). Development and validation of a risk-score model for type 2 diabetes: A cohort study of a rural adult Chinese population. PLoS ONE, 11(4), 1–13. https://doi.org/10.1371/journal.pone.0152054

Published
2022-04-21
How to Cite
Puspasari, S., Supriatin, E., Hayati, S. N., & Putri, T. A. R. K. (2022). PENGEMBANGAN FRIDEM SEBAGAI SCREENING TOOL DIABETES MELLITUS TIPE 2 BAGI MASYARAKAT INDONESIA. Jurnal Keperawatan BSI, 10(1), 1-6. Retrieved from http://ejurnal.ars.ac.id/index.php/keperawatan/article/view/693

Most read articles by the same author(s)